Findings presented that overall and disease-free survival in patients with cervical cancer with low KAT2B expression were signally shorter than those in patients with high expression (Figure 2a and b), which indicated that KAT2B was a potential prognostic marker for cervical carcinoma, which might mainly work in tumor suppressor genes. The gene discussed is KAT2B; the disease is cervical carcinoma.